Abstract
Portugal, unlike its neighbors, Spain and Italy, has so far managed to maintain the flattening of the epidemiological curve of Infections by SARS-CoV 2. The pandemic response strategy in this country included the implementation of measures commonly referred to as non-pharmacological, as well as the rapid growth of responsiveness to perform RTPCR tests for the diagnosis of COVID-19. The clinical and epidemiological reflection of the measures adopted political and economic considerations, is made, and ends with a bioethical analysis of the methodologies implemented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
